Table 1.
Summary of guideline recommendations pre-, during and post-pregnancy and perinatal medication recommendations.
| Pre-pregnancy |
Pregnancy |
Postpartum |
Medication recommendations |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Country of origin | Year of publication | Perinatal specific | Pregnancy planning | Continue AD | Switch AD | Psychotherapy for new depression | Medication for new depression | Continue AD | Switch AD | Psychotherapy for new depression | Medication for new depression | Continue AD | Switch AD | Breastfeeding | Psychotherapy for new depression | Medication for new depression | Preferred medication | Non-preferred medication | |
| ACOG | USA | 2008 | √ | 0 | + | Paroxetine | |||||||||||||
| APA | USA | 2010 | + | + | 0 | 0 | + | + | + | 0 | 0 | Paroxetine | |||||||
| BC | Canada | 2014 | √ | + | – | 0 | – | + | + | + | + | Paroxetine | |||||||
| BMU | China | 2015 | + | + | |||||||||||||||
| CANMAT | Canada | 2016 | + | + | + | + | + | + | Sertraline, (es)citalopram | Paroxetine, fluoxetine | |||||||||
| COPE | Australia | 2017 | √ | + | + | + | + | + | + | + | |||||||||
| Danish | Denmark | 2014 | √ | + | + | + | 0 | Sertraline, citalopram | Paroxetine, fluoxetine | ||||||||||
| DGPPN | Germany | 2017 | + | 0 | 0 | Paroxetine, fluoxetine | |||||||||||||
| NFOG | Norway | 2015 | √ | – | + | – | + | + | + | Paroxetine | |||||||||
| NHS | Spain | 2014 | Fluoxetine | Paroxetine | |||||||||||||||
| NICE | UK | 2014 | √ | + | + | + | 0 | 0 | + | + | 0 | 0 | + | + | + | ||||
| NVOG | Netherlands | 2012 | √ | + | – | 0 | + | + | Paroxetine | ||||||||||
| MOH | Singapore | 2012 | 0 | + | + | + | + | ||||||||||||
| RANZCP | Australia and New Zealand | 2015 | + | + | + | + | Paroxetine, fluoxetine, venlafaxine | ||||||||||||
| SIGN | UK | 2012 | √ | + | – | + | + | + | + | + | Paroxetine | ||||||||
| VA/DoD | USA | 2016 | + | + | Sertraline | Paroxetine, fluoxetine | |||||||||||||
√: yes; +: advised by guideline; –: discouraged by guideline; 0: mentioned but no steering recommendation; ACOG: American College of Obstetricians and Gynaecologists; APA: American Psychiatric Association; VA/DoD: Department of Veterans Affairs/Department of Defense; BC: British Columbia Reproductive Mental Health Program & Perinatal Services British Columbia; BMU: Beijing Medical University; CANMAT: Canadian Network for Mood and Anxiety Treatments; COPE: Centre of Perinatal Excellence; RANZCP: Royal Australian and New Zealand College of Psychiatrists; NICE: National Institute for Health and Care Excellence; SIGN: Scottish Intercollegiate Guidelines Network; Danish: Danish Psychiatric Society, Danish Society for Obstetrics and Gynaecology, Danish Paediatric Society and Danish Company for Clinical Pharmacology; DGPPN: German Society for Psychiatry and Psychotherapy, Psychosomatics and Neurology; NVOG: Dutch Society of Obstetrics and Gynaecology; NFOG: Nordic Federation of Societies of Obstetrics and Gynaecology; NHS: Spanish ministry of health, social services and equality; MOH: Ministry of Health, Singapore.